| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| Mi | Modular Medical, Inc.: Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump | 158 | ACCESS Newswire | Completed Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towards... ► Artikel lesen | |
| Di | Modular Medical, Inc.: Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery | 194 | ACCESS Newswire | 97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved OutcomesConducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless... ► Artikel lesen | |
| 01.07. | Modular Medical reicht Software-Verbesserungen für Pivot-System bei FDA ein | 2 | Investing.com Deutsch | ||
| 01.07. | Modular Medical, Inc.: Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements | 234 | ACCESS Newswire | Submission Covers Software Enhancements for Patient Flexibility and Customization of Pivot SAN DIEGO, CA / ACCESS Newswire / July 1, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company")... ► Artikel lesen | |
| 30.06. | Modular Medical startet kommerzielle Einführung seiner Insulinpumpe | 5 | Investing.com Deutsch | ||
| 30.06. | Modular Medical begins commercial insulin pump deployment | 2 | Investing.com | ||
| 30.06. | Modular Medical, Inc.: Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump | 355 | ACCESS Newswire | First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial CompanyPivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insulin-Dependent... ► Artikel lesen | |
| 30.06. | EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump | 2 | Benzinga.com | ||
| 29.06. | Modular Medical, Inc. - 10-K, Annual Report | 5 | SEC Filings | ||
| 26.06. | Modular Medical begins shipping Pivot insulin pump to doctors | 1 | Investing.com | ||
| 26.06. | Modular Medical, Inc.: Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps | 263 | ACCESS Newswire | Pivot starter kits are now shipping to multiple endocrinology practices SAN DIEGO, CA / ACCESS Newswire / June 26, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a... ► Artikel lesen | |
| 24.06. | Modular Medical launches Pivot tubeless insulin patch pump | 1 | MassDevice | ||
| 24.06. | Modular Medical, Inc.: Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion | 372 | ACCESS Newswire | The Pivot tubeless insulin patch pump is now commercially available in the U.S. following FDA 510(k) clearance in AprilPivot represents a differentiated solution for insulin-dependent adults still on... ► Artikel lesen | |
| 24.06. | EXCLUSIVE: Modular Medical Transitions To Commercial Stage With Pivot Insulin Pump Launch | 2 | Benzinga.com | ||
| 04.06. | Modular Medical, Inc.: Modular Medical Launches New Website for Pivot Tubeless Insulin Patch Pump | 311 | ACCESS Newswire | Initial patients expected in June 2026 SAN DIEGO, CA / ACCESS Newswire / June 4, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric... ► Artikel lesen | |
| 20.05. | Modular Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.04. | Modular Medical, Inc.: Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026 | 382 | ACCESS Newswire | Meet with Modular Medical CEO Jeb BesserThere are 4.8 million individuals with diabetes in the US that require daily insulin. Only 20% currently use an insulin pump.Discover Modular Medical's Pivot... ► Artikel lesen | |
| 20.04. | Modular Medical prices $3.4M offering at $4.50 per share | 2 | Seeking Alpha | ||
| 20.04. | Modular Medical platziert Kapitalerhöhung über 3,4 Mio. US-Dollar mit deutlichem Abschlag | 3 | Investing.com Deutsch | ||
| 20.04. | Modular Medical prices $3.4 million stock offering at $4.50/share | 2 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,443 | +0,91 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| LIFEWARD | 7,800 | -2,50 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| IMUNON | 1,790 | +4,68 % | Celsion Bank wird Mitglied des Liechtensteinischen Bankenverbandes | Vaduz - Die Celsion Bank AG ist seit 1. Juli 2026 Vollmitglied des Liechtensteinischen Bankenverbandes (LBV). Die Celsion Bank bringt ein klares Profil mit Fokus auf digitale Vermögenswerte ein und... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 45,200 | +4,63 % | Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance | First quarter revenue growth of 1.6%First quarter diluted EPS of $(0.39); adjusted diluted EPS of $0.10First quarter operating cash flow of $12.8 million MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| INSPIREMD | 0,625 | 0,00 % | InspireMD Inc.: InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures | MIAMI, June 08, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| GT BIOPHARMA | 0,343 | -7,05 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| MYOMO | 0,979 | 0,00 % | MYOMO, INC. - 8-K, Current Report | ||
| INOGEN | 5,500 | 0,00 % | Inogen appoints Andy Reding as chief operating officer | ||
| INTELLIGENT BIO SOLUTIONS | 2,290 | +1,78 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,588 | +0,15 % | Lexaria Bioscience Corp. - 10-Q, Quarterly Report | ||
| INCANNEX HEALTHCARE | 3,220 | +1,58 % | Incannex Healthcare: Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea | MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| GLUCOTRACK | 0,525 | -0,76 % | Glucotrack, Inc.; Lokahi Therapeutics: Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform | RUTHERFORD, N.J. and LA JOLLA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lokahi Therapeutics... ► Artikel lesen | |
| LENSAR | 5,770 | +0,17 % | LENSAR, Inc.: LENSAR Reports First Quarter 2026 Results and Provides Business Update | 7 ALLY Robotic Cataract Laser Systems® ("ALLY System") Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser... ► Artikel lesen | |
| JIN MEDICAL INTERNATIONAL | 1,960 | 0,00 % | Jin Medical International Ltd. - 6-K, Report of foreign issuer | ||
| HEARTBEAM | 0,660 | +17,71 % | HeartBeam receives patent for multi-modal cardiac sensing device |